1. Home
  2. RENX vs MBIO Comparison

RENX vs MBIO Comparison

Compare RENX & MBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RenX Enterprises Corp. Common Stock

RENX

RenX Enterprises Corp. Common Stock

HOLD

Current Price

$1.78

Market Cap

4.7M

Sector

N/A

ML Signal

HOLD

MBIO

Mustang Bio Inc.

HOLD

Current Price

$0.51

Market Cap

4.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RENX
MBIO
Founded
2021
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.7M
4.1M
IPO Year
2023
2023

Fundamental Metrics

Financial Performance
Metric
RENX
MBIO
Price
$1.78
$0.51
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
70.8K
16.3K
Earning Date
05-22-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
98.99
EPS
N/A
N/A
Revenue
$8,220,449.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
3860.67
N/A
52 Week Low
$0.09
$0.51
52 Week High
$3.48
$1.84

Technical Indicators

Market Signals
Indicator
RENX
MBIO
Relative Strength Index (RSI) N/A 32.39
Support Level N/A N/A
Resistance Level N/A $0.56
Average True Range (ATR) 0.00 0.02
MACD 0.00 -0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
RENX
MBIO

About RENX RenX Enterprises Corp. Common Stock

RenX Enterprises Corp is engaged in real property development using purpose-built, prefabricated modules constructed from both wood and steel. The Company's operations mainly focused on the acquisition, entitlement, and development of residential properties in high-growth markets across the United States. These efforts included the direct acquisition of land, strategic investments in real estate entities, and joint venture partnerships targeting green, single-family, and multifamily housing projects. The company operates in four segments: real estate development, technology, compost sales, and logistics. The company generates from the compost sales.

About MBIO Mustang Bio Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs into potential cures for difficult-to-treat cancers. It acquires rights to these technologies by licensing or otherwise acquiring an ownership interest in the technologies, funding their research and development, and eventually either out-licensing or bringing the technologies to market. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

Share on Social Networks: